Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...
In India, the drugOzempic is not licensed for weight loss, but as anti-diabetic medication, warns Dr Chandrakant Lahariya. You can post your health-related questions to rediffGURU Dr ...
Results that may be inaccessible to you are currently showing.